Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.45	57.05	111	134.34	129.32	157.53
Cash & Short-Term Investments	46.45	57.05	111	134.34	129.32	157.53
Cash Growth	-49.53%	-48.60%	-17.38%	3.89%	-17.91%	70.17%
Other Receivables	-	-	-	1.35	6.93	-
Total Trade Receivables	-	-	-	1.35	6.93	-
Other Current Assets	2.28	1.54	2.07	2.68	3.96	3.54
Total Current Assets	48.73	58.59	113.07	138.37	140.2	161.07
Net Property, Plant & Equipment	9.29	9.9	12.32	14.85	17.45	16.33
Other Long-Term Assets	-	0.91	1.54	21.62	2.59	1.86
Total Assets	58.02	69.4	126.93	174.83	160.25	179.25
Accounts Payable	3.57	0.75	3.04	1.34	1.22	2.04
Accrued Expenses	4.52	5.41	10.59	8.86	14.15	8.77
Current Portion of Long-Term Debt	28.83	28.24	-	6.67	-	-
Current Portion of Leases	1.6	1.75	1.56	1.61	2.08	1.07
Unearned Revenue	-	-	-	0.91	6.53	-
Total Current Liabilities	38.52	36.15	15.18	19.38	23.99	11.87
Long-Term Debt	-	-	26.1	32.66	-	-
Long-Term Leases	7.22	7.68	9.44	10.99	12.6	14.59
Other Long-Term Liabilities	0.09	0.76	2.83	0.43	1.32	-
Total Long-Term Liabilities	7.3	8.44	38.36	44.08	13.92	14.59
Total Liabilities	45.82	44.59	53.54	63.46	37.91	26.46
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	501.14	500.21	487.97	455.44	429.04	405.68
Retained Earnings	-488.94	-475.41	-414.59	-344.07	-306.71	-252.9
Total Common Shareholders' Equity	12.2	24.81	73.39	111.37	122.34	152.79
Shareholders' Equity	12.2	24.81	73.39	111.37	122.34	152.79
Total Liabilities & Equity	58.02	69.4	126.93	174.83	160.25	179.25
Total Debt	37.65	37.67	37.09	51.92	14.68	15.66
Net Cash (Debt)	8.8	19.38	73.91	82.42	114.63	141.87
Net Cash Growth	-54.60%	-73.78%	-10.33%	-28.10%	-19.20%	57.58%
Net Cash Per Share	0.19	0.41	1.69	2.31	3.97	7.69
Book Value	12.2	24.81	73.39	111.37	122.34	152.79
Book Value Per Share	0.26	0.53	1.67	3.12	4.24	8.28
Tangible Book Value	12.2	24.81	73.39	111.37	122.34	152.79
Tangible Book Value Per Share	0.26	0.53	1.67	3.12	4.24	8.28

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error